COHN vs HIVE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

COHN

39.8
AI Score
VS
HIVE Wins

HIVE

57.7
AI Score

Investment Advisor Scores

COHN

40score
Recommendation
SELL

HIVE

58score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric COHN HIVE Winner
Revenue 41.89M 79.12M HIVE
Net Income -2.20M -142.91M COHN
Net Margin -5.3% -180.6% COHN
ROE -7.1% -33.8% COHN
ROA -0.0% -15.5% COHN
Total Assets 6.08B 924.64M COHN
Cash 235.02M 208.04M COHN

Relative Price Performance (Last 90 Days)

COHN 1M: -6.4% · 3M: -29.5% HIVE 1M: -42.7% · 3M: -36.2%

Current Technical Phase

COHN

Markdown
Sell / avoid

Price below a falling SMA50 (slope -9.8%), weak momentum, RSI 35

RSI (14): 35.2 · Price: $9.50

HIVE

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.1%), weak momentum, RSI 26

RSI (14): 25.6 · Price: $2.03

Fundamentals Snapshot

Metric COHN HIVE
Market Cap — —
Forward P/E 5.1 -4.0
Trailing P/E 2.1 —
Revenue (TTM) — —
Revenue Growth 0.2% 0.7%
Gross Margin 1.0% 0.4%
Operating Margin 0.2% -0.6%
EPS 4.68 -1.32
Dividend Yield 0.10% —

Frequently Asked Questions

Based on our detailed analysis, HIVE is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.